Search Results - "Coetzee, Lindi M"

An integrated tiered service delivery model (ITSDM) based on local CD4 testing demands can improve turn-around times and save costs whilst ensuring accessible and scalable CD4 services across a national programme by Glencross, Deborah K, Coetzee, Lindi M, Cassim, Naseem

“…The South African National Health Laboratory Service (NHLS) responded to HIV treatment initiatives with two-tiered CD4 laboratory services in 2004. Increasing…”
Get full text

Estimating implementation and operational costs of an integrated tiered CD4 service including laboratory and point of care testing in a remote health district in South Africa by Cassim, Naseem, Coetzee, Lindi M, Schnippel, Kathryn, Glencross, Deborah K

“…An integrated tiered service delivery model (ITSDM) has been proposed to provide 'full-coverage' of CD4 services throughout South Africa. Five tiers are…”
Get full text

Screening HIV-Infected Patients with Low CD4 Counts for Cryptococcal Antigenemia prior to Initiation of Antiretroviral Therapy: Cost Effectiveness of Alternative Screening Strategies in South Africa by Larson, Bruce A, Rockers, Peter C, Bonawitz, Rachael, Sriruttan, Charlotte, Glencross, Deborah K, Cassim, Naseem, Coetzee, Lindi M, Greene, Gregory S, Chiller, Tom M, Vallabhaneni, Snigdha, Long, Lawrence, van Rensburg, Craig, Govender, Nelesh P

“…In 2015 South Africa established a national cryptococcal antigenemia (CrAg) screening policy targeted at HIV-infected patients with CD4+ T-lymphocyte (CD4)…”
Get full text

Establishing the cost of Xpert MTB/RIF mobile testing in high-burden peri-mining communities in South Africa by Cassim, Naseem, Coetzee, Lindi M., Makuraj, Abel L., Stevens, Wendy S., Glencross, Deborah K.

“…Background: Globally, tuberculosis remains a major cause of mortality, with an estimated 1.3 million deaths per annum. The Xpert MTB/RIF assay is used as the…”
Get full text

Categorising specimen referral delays for CD4 testing: How inter-laboratory distances and travel times impact turn-around time across a national laboratory service in South Africa by Cassim, Naseem, Coetzee, Lindi M., Glencross, Deborah K.

“…Abstract only…”
Get full text

Timely delivery of laboratory efficiency information, part I : developing an interactive turnaround time dashboard at a high-volume laboratory by Tepper, Manfred E., Glencross, Deborah K., Cassim, Naseem, Coetzee, Lindi M.

“…Background: Mean turn-around time (TAT) reporting for testing laboratories in a national network is typically static and not immediately available for…”
Get full text

Timely delivery of laboratory efficiency information, part II : assessing the impact of a turn-around time dashboard at a high-volume laboratory by Coetzee, Lindi M., Tepper, Manfred E.E., Perelson, Louella, Glencross, Deborah K., Cassim, Naseem

“…Background: In South Africa’s National Health Laboratory Service, ad hoc mean turn-around time (TAT) reporting is an important indicator of performance…”
Get full text

Performance of the PointCare NOW system for CD4 counting in HIV patients based on five independent evaluations by Bergeron, Michèle, Daneau, Géraldine, Ding, Tao, Sitoe, Nadia E, Westerman, Larry E, Stokx, Jocelijn, Jani, Ilesh V, Coetzee, Lindi M, Scott, Lesley, De Weggheleire, Anja, Boel, Luc, Stevens, Wendy S, Glencross, Deborah K, Peter, Trevor F

“…Point-of-care (POC) CD4 testing can improve access to treatment by enabling decentralization and reducing patient loss-to-follow-up. As new POC CD4…”
Get full text

Addressing antiretroviral therapy-related diagnostic coverage gaps across South Africa using a programmatic approach by Stevens, Wendy S., Coetzee, Lindi M., Cassim, Naseem, Glencross, Deborah K.

“…Background: A major challenge facing South Africa is the concomitant HIV and tuberculosis epidemics. The National Health Laboratory Service provides testing…”
Get full text

District and sub-district analysis of cryptococcal antigenaemia prevalence and specimen positivity in KwaZulu-Natal, South Africa by Glencross, Deborah K., Cassim, Naseem, Govender, Nelesh P., Coetzee, Lindi M.

“…Background: Cryptococcal meningitis (CM) is a leading cause of mortality among HIVpositive South Africans. Reflex cryptococcal antigen (CrAg) testing of…”
Get full text

Programmatic implications of implementing the relational algebraic capacitated location (RACL) algorithm outcomes on the allocation of laboratory sites, test volumes, platform distribution and space requirements by Smith, Honora, Coetzee, Lindi M., Cassim, Naseem, Glencross, Deborah K.

“…Introduction: CD4 testing in South Africa is based on an integrated tiered service delivery model that matches testing demand with capacity. The National…”
Get full text

Compliance to HIV treatment monitoring guidelines can reduce laboratory costs by Cassim, Naseem, Coetzee, Lindi M, Schnippel, Kathryn, Glencross, Deborah K

“…Panel tests are a predetermined group of tests commonly requested together to provide a comprehensive and conclusive diagnosis, for example, liver function…”
Get full text

Correction: Performance of the PointCare NOW System for CD4 Counting in HIV Patients Based on Five Independent Evaluations by Bergeron, Michèle, Daneau, Géraldine, Ding, Tao, Sitoe, Nadia E., Westerman, Larry E., Stokx, Jocelijn, Jani, Ilesh V., Coetzee, Lindi M., Scott, Lesley, De Weggheleire, Anja, Boel, Luc, Stevens, Wendy S., Glencross, Deborah K., Peter, Trevor F.

“…The SA NHLS is the sole owner of the PLG CD4 patent, and receives royalties related to licensing agreement with BC Miami. (2012) Correction: Performance of the…”
Get full text

Retrospective Assessment of a National Reflex Cryptococcal Antigen Screening Program in South Africa Through Interlaboratory Comparison of Lateral Flow Assay Results by Blasich, Nozuko P, Coetzee, Lindi M, Sriruttan, Charlotte, DeSanto, Daniel, Greene, Gregory S, Glencross, Deborah K, Govender, Nelesh P

“…Abstract Objective Reflex cryptococcal antigen (CrAg) screening of blood specimens with a CD4 count of <100 cells/µL was performed at 45 South African CD4…”
Get full text

Performance evaluation of the Pima™ point‐of‐care CD4 analyser using capillary blood sampling in field tests in South Africa by Glencross, Deborah K, Coetzee, Lindi M, Faal, Mamsallah, Masango, Martin, Stevens, Wendy S, Venter, WD Francois, Osih, Regina

“…Background Point‐of‐care CD4 testing can provide immediate CD4 reporting at HIV‐testing sites. This study evaluated performance of capillary blood sampling…”
Get full text

Decentralised CD38 activation monitoring: Aspects of practical implementation and standardisation by Moodley, Keshendree, Coetzee, Lindi M., Glencross, Deborah K.

“…In light of the HIV pandemic, significant strides have been made in improving treatment options for patients. Technologies to monitor the progress of a patient…”
Get full text

Siting of HIV/AIDS diagnostic equipment in South Africa: a case study in locational analysis by Smith, Honora K., Smith, Jon P., Glencross, Deborah K., Cassim, Naseem, Coetzee, Lindi M., Carmona, Sergio, Stevens, Wendy

“…This paper describes a practical application of locational analysis to the siting of HIV/AIDS diagnostic equipment in laboratories across South Africa…”
Get full text

A model for continuous quality control incorporating sample‐to‐sample assessment of optical alignment, fluorescence sensitivity, and volumetric operation of flow cytometers by Lawrie, Denise, Coetzee, Lindi M., Glencross, Deborah K.

“…Background: Bead count rate (BCR) monitoring successfully identifies pipetting error during single platform CD4 enumeration. Despite rigorous prescribed…”
Get full text

From research tool to routine test: CD38 monitoring in HIV patients by Coetzee, Lindi M., Tay, Szun Szun, Lawrie, Denise, Janossy, George, Glencross, Deborah K.

“…Background: CD38 expression on CD8+ T lymphocytes in HIV‐infected patients is monitored by flow cytometry (FCM). There is however no consensus re CD38…”
Get full text

Large‐scale affordable Panleucogated CD4+ testing with proactive internal and external quality assessment: In support of the South African national comprehensive care, treatment and management programme for HIV and AIDS by Glencross, Deborah K., Janossy, George, Coetzee, Lindi M., Lawrie, Denise, Aggett, Hazel M., Scott, Lesley E., Sanne, Ian, McIntyre, James A., Stevens, Wendy

“…Background: In order to expand the treatment of human immunodeficiency virus‐1 (HIV) infected patients in Africa, millions will require cost‐effective CD4…”
Get full text